Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players├óÔéČÔäó financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Americas Cancer Biologic Therapy Companies

Companies in the Americas specializing in cancer biological therapy contribute to oncology by developing and providing biologically derived therapies for cancer treatment. These therapies may include monoclonal antibodies, immunotherapies, and targeted therapies that harness the body's immune system to combat cancer cells, improving treatment outcomes.

Americas Cancer Biological Therapy Companies


Latest Americas Cancer Biological Therapy Companies Updates:

Dec 2023

Bristol-Myers SquibbReceived FDA approval for their Opdivo® (nivolumab) and Yervoy® (ipilimumab) combination therapy for first-line treatment of advanced non-small cell lung cancer (NSCLC) with high PD-L1 expression.Partnered with academic institutions to explore the potential of their biologic therapies for treating additional cancer types and early-stage disease.

Roche Holding AG Announced positive Phase III data for their Tecentriq® (atezolizumab) in combination with chemotherapy for the treatment of advanced bladder cancer.Launched their Foundation® Medicine platform in Brazil, providing personalized genomic testing and treatment recommendations for cancer patients.

Merck & Co.Presented encouraging data at a major oncology conference on their Keytruda® (pembrolizumab) for the treatment of head and neck cancer.Collaborated with government agencies in Latin America to improve access to their cancer biologic therapies for underserved populations.

Eli Lilly and Company Received FDA approval for their Verzenio® (abemaciclib) as a first-line treatment for advanced HR-positive, HER2-negative breast cancer.Announced plans to expand their clinical trial portfolio in the Americas to include more diverse patient populations.

AbbVie Launched their Venclexta® (venetoclax) in combination with Rituximab for the treatment of chronic lymphocytic leukemia (CLL) in Argentina and Brazil.Partnered with patient advocacy groups to raise awareness about CLL and improve access to treatment options.

List of Americas Cancer Biological Therapy Key companies in the market

  • Hoffmann-La Roche AG,

  • GSK, Merck & Co.,

  • Novartis International AG, Inc.,

  • GlaxoSmithKline Plc,

  • Bristol-Myers Squibb,

  • Eli Lilly,

  • Amgen Inc.,

  • Spectrum Pharmaceuticals, Inc.,

  • Seattle Genetics, Inc.,

  • Celgene Corporation

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.